Krónikus limfoid leukémia (CLL): vizsgálatok itt: Egyesült Államok
184 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- Where
- Chapel Hill, Cleveland, Columbus, Dallas, Denver, Nashville, Portland, Sarasota, Seattle
- Életkor
- 18 év and over
- People
- 60
- Run by
- Accutar Biotechnology Inc
See details and how to joinNCT05780034 - Korai 1. fázisNot yet taking people in Egyesült ÁllamokSafety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
- Where
- Columbus
- Életkor
- Up to 30 év
- People
- 12
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05779930 - 2. fázisTaking peopleLP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
- Where
- Cincinnati
- Életkor
- 18 év and over
- People
- 34
- Run by
- Zulfa Omer
See details and how to joinNCT06978088 - 1. fázisTaking peopleCAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
- Where
- Boston, Durham
- Életkor
- 18 év and over
- People
- 18 worldwide
- Run by
- Catapult Therapeutics
See details and how to joinNCT04704323 · EU 2024-516341-39-00 - 1. fázisTaking peoplePrevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Where
- Boston, Duarte, Minneapolis, New York, Seattle
- Életkor
- 18 év and over
- People
- 36
- Run by
- Tr1X, Inc.
See details and how to joinNCT06462365 - 1. fázisTaking peopleStudy of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
- Where
- Boston, Canton, Charlotte, Cleveland, Duarte, Jacksonville, Seattle
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT04215809 - No phaseTaking peopleA Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
- Where
- Milwaukee
- Életkor
- 18 év and over
- People
- 300
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06788639 - 2. fázisTaking peopleLocal Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
- Where
- Pittsburgh
- Életkor
- 18 év to 79 év
- People
- 30
- Run by
- John Lister
See details and how to joinNCT05281809 - 1/2. fázisTaking peopleSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Where
- Cincinnati, Columbus, Dallas, Goshen
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT04502394